Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 124

1.

Brain metastases.

Achrol AS, Rennert RC, Anders C, Soffietti R, Ahluwalia MS, Nayak L, Peters S, Arvold ND, Harsh GR, Steeg PS, Chang SD.

Nat Rev Dis Primers. 2019 Jan 17;5(1):5. doi: 10.1038/s41572-018-0055-y. Review.

PMID:
30655533
2.

Diabetes Insipidus following Endoscopic Transsphenoidal Surgery for Pituitary Adenoma.

Ajlan AM, Abdulqader SB, Achrol AS, Aljamaan Y, Feroze AH, Katznelson L, Harsh GR.

J Neurol Surg B Skull Base. 2018 Apr;79(2):117-122. doi: 10.1055/s-0037-1604363. Epub 2017 Aug 3.

PMID:
29868315
3.

Porcine small intestine submucosal grafts improve remucosalization and progenitor cell recruitment to sites of upper airway tissue remodeling.

Nayak JV, Rathor A, Grayson JW, Bravo DT, Velasquez N, Noel J, Beswick DM, Riley KO, Patel ZM, Cho DY, Dodd RL, Thamboo A, Choby GW, Walgama E, Harsh GR, Hwang PH, Clemons L, Lowman D, Richman JS, Woodworth BA.

Int Forum Allergy Rhinol. 2018 Oct;8(10):1162-1168. doi: 10.1002/alr.22156. Epub 2018 Jun 1.

PMID:
29856526
4.

Natural history of Rathke's cleft cysts: A retrospective analysis of a two centres experience.

Sala E, Moore JM, Amorin A, Carosi G, Martinez H Jr, Harsh GR, Arosio M, Mantovani G, Katznelson L.

Clin Endocrinol (Oxf). 2018 May 21. doi: 10.1111/cen.13744. [Epub ahead of print]

PMID:
29781512
5.

First-in-human intraoperative near-infrared fluorescence imaging of glioblastoma using cetuximab-IRDye800.

Miller SE, Tummers WS, Teraphongphom N, van den Berg NS, Hasan A, Ertsey RD, Nagpal S, Recht LD, Plowey ED, Vogel H, Harsh GR, Grant GA, Li GH, Rosenthal EL.

J Neurooncol. 2018 Aug;139(1):135-143. doi: 10.1007/s11060-018-2854-0. Epub 2018 Apr 6.

6.

CyberKnife robotic radiosurgery in the multimodal management of acromegaly patients with invasive macroadenoma: a single center's experience.

Sala E, Moore JM, Amorin A, Martinez H Jr, Bhowmik AC, Lamsam L, Chang S, Soltys SG, Katznelson L, Harsh GR.

J Neurooncol. 2018 Jun;138(2):291-298. doi: 10.1007/s11060-018-2793-9. Epub 2018 Feb 10.

PMID:
29429125
7.

Hemangiopericytoma in the Olfactory Groove: A Rare and Unusual Presentation.

Gupta R, Moore JM, Miller K, Harsh GR 4th.

Cureus. 2017 Nov 25;9(11):e1875. doi: 10.7759/cureus.1875.

8.

Adrenal Axis Insufficiency After Endoscopic Transsphenoidal Resection of Pituitary Adenomas.

Ajlan A, Almufawez KA, Albakr A, Katznelson L, Harsh GR 4th.

World Neurosurg. 2018 Apr;112:e869-e875. doi: 10.1016/j.wneu.2018.01.182. Epub 2018 Feb 5.

PMID:
29421453
9.

CyberKnife Radiosurgery in the Multimodal Management of Patients with Cushing Disease.

Moore JM, Sala E, Amorin A, Martinez H Jr, Bhowmik AC, Chang SD, Soltys SG, Harsh GR, Katznelson L.

World Neurosurg. 2018 Apr;112:e425-e430. doi: 10.1016/j.wneu.2018.01.057. Epub 2018 Jan 31.

PMID:
29355797
10.

Imaging changes over 18 months following stereotactic radiosurgery for brain metastases: both late radiation necrosis and tumor progression can occur.

Fujimoto D, von Eyben R, Gibbs IC, Chang SD, Li G, Harsh GR, Hancock S, Fischbein N, Soltys SG.

J Neurooncol. 2018 Jan;136(1):207-212. doi: 10.1007/s11060-017-2647-x. Epub 2017 Nov 2.

PMID:
29098569
11.

Neurosurgical Resident Error: A Survey of U.S. Neurosurgery Residency Training Program Directors' Perceptions.

Gupta R, Moore JM, Adeeb N, Griessenauer CJ, Schneider AM, Gandhi CD, Harsh GR, Thomas AJ, Ogilvy CS.

World Neurosurg. 2018 Jan;109:e563-e570. doi: 10.1016/j.wneu.2017.10.022. Epub 2017 Oct 16.

PMID:
29042335
12.

Vorinostat and Concurrent Stereotactic Radiosurgery for Non-Small Cell Lung Cancer Brain Metastases: A Phase 1 Dose Escalation Trial.

Choi CYH, Wakelee HA, Neal JW, Pinder-Schenck MC, Yu HM, Chang SD, Adler JR, Modlin LA, Harsh GR, Soltys SG.

Int J Radiat Oncol Biol Phys. 2017 Sep 1;99(1):16-21. doi: 10.1016/j.ijrobp.2017.04.041. Epub 2017 May 6.

PMID:
28816142
13.

Cavernous Sinus Involvement by Pituitary Adenomas: Clinical Implications and Outcomes of Endoscopic Endonasal Resection.

Ajlan A, Achrol AS, Albakr A, Feroze AH, Westbroek EM, Hwang P, Harsh GR 4th.

J Neurol Surg B Skull Base. 2017 Jun;78(3):273-282. doi: 10.1055/s-0036-1598022. Epub 2017 Jan 23.

14.

Phase 1/2 Trial of 5-Fraction Stereotactic Radiosurgery With 5-mm Margins With Concurrent and Adjuvant Temozolomide in Newly Diagnosed Supratentorial Glioblastoma: Health-Related Quality of Life Results.

Pollom EL, Fujimoto D, Wynne J, Seiger K, Modlin LA, Jacobs LR, Azoulay M, von Eyben R, Tupper L, Gibbs IC, Hancock SL, Li G, Chang SD, Adler JR, Harsh GR, Harraher C, Nagpal S, Thomas RP, Recht LD, Choi CYH, Soltys SG.

Int J Radiat Oncol Biol Phys. 2017 May 1;98(1):123-130. doi: 10.1016/j.ijrobp.2017.01.242. Epub 2017 Feb 7.

15.

Revealing cancer subtypes with higher-order correlations applied to imaging and omics data.

Graim K, Liu TT, Achrol AS, Paull EO, Newton Y, Chang SD, Harsh GR 4th, Cordero SP, Rubin DL, Stuart JM.

BMC Med Genomics. 2017 Mar 31;10(1):20. doi: 10.1186/s12920-017-0256-3.

16.

KLF6 depletion promotes NF-κB signaling in glioblastoma.

Masilamani AP, Ferrarese R, Kling E, Thudi NK, Kim H, Scholtens DM, Dai F, Hadler M, Unterkircher T, Platania L, Weyerbrock A, Prinz M, Gillespie GY, Harsh GR IV, Bredel M, Carro MS.

Oncogene. 2017 Jun 22;36(25):3562-3575. doi: 10.1038/onc.2016.507. Epub 2017 Feb 6.

17.

Magnetic resonance perfusion image features uncover an angiogenic subgroup of glioblastoma patients with poor survival and better response to antiangiogenic treatment.

Liu TT, Achrol AS, Mitchell LA, Rodriguez SA, Feroze A, Iv M, Kim C, Chaudhary N, Gevaert O, Stuart JM, Harsh GR, Chang SD, Rubin DL.

Neuro Oncol. 2017 Jul 1;19(7):997-1007. doi: 10.1093/neuonc/now270.

18.

A Phase I/II Trial of 5 Fraction Stereotactic Radiosurgery With 5-mm Margins With Concurrent and Adjuvant Temozolomide in Newly Diagnosed Supratentorial Glioblastoma Multiforme.

Azoulay M, Ho CK, Fujimoto DK, Modlin LA, Gibbs IC, Hancock SL, Li G, Chang SD, Adler JR Jr, Harsh GR, Nagpal S, Thomas R, Recht L, Choi CY, Soltys SG.

Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S):E131-E132. doi: 10.1016/j.ijrobp.2016.06.921. No abstract available.

PMID:
27673859
19.

Pituitary Apoplexy Associated with Carotid Compression and a Large Ischemic Penumbra.

Sussman ES, Ho AL, Pendharkar AV, Achrol AS, Harsh GR 4th.

World Neurosurg. 2016 Aug;92:581.e7-581.e13. doi: 10.1016/j.wneu.2016.06.040. Epub 2016 Jun 16.

PMID:
27319311
20.

Dose-Response Modeling of the Visual Pathway Tolerance to Single-Fraction and Hypofractionated Stereotactic Radiosurgery.

Hiniker SM, Modlin LA, Choi CY, Atalar B, Seiger K, Binkley MS, Harris JP, Liao YJ, Fischbein N, Wang L, Ho A, Lo A, Chang SD, Harsh GR, Gibbs IC, Hancock SL, Li G, Adler JR, Soltys SG.

Semin Radiat Oncol. 2016 Apr;26(2):97-104. doi: 10.1016/j.semradonc.2015.11.008. Epub 2015 Dec 4. Review.

PMID:
27000505
21.

Multiple Subsets of Brain Tumor Initiating Cells Coexist in Glioblastoma.

Rennert RC, Achrol AS, Januszyk M, Kahn SA, Liu TT, Liu Y, Sahoo D, Rodrigues M, Maan ZN, Wong VW, Cheshier SH, Chang SD, Steinberg GK, Harsh GR, Gurtner GC.

Stem Cells. 2016 Jun;34(6):1702-7. doi: 10.1002/stem.2359. Epub 2016 Mar 28.

22.

Computational Identification of Tumor Anatomic Location Associated with Survival in 2 Large Cohorts of Human Primary Glioblastomas.

Liu TT, Achrol AS, Mitchell LA, Du WA, Loya JJ, Rodriguez SA, Feroze A, Westbroek EM, Yeom KW, Stuart JM, Chang SD, Harsh GR 4th, Rubin DL.

AJNR Am J Neuroradiol. 2016 Apr;37(4):621-8. doi: 10.3174/ajnr.A4631. Epub 2016 Jan 7.

23.

Magnetic resonance image features identify glioblastoma phenotypic subtypes with distinct molecular pathway activities.

Itakura H, Achrol AS, Mitchell LA, Loya JJ, Liu T, Westbroek EM, Feroze AH, Rodriguez S, Echegaray S, Azad TD, Yeom KW, Napel S, Rubin DL, Chang SD, Harsh GR 4th, Gevaert O.

Sci Transl Med. 2015 Sep 2;7(303):303ra138. doi: 10.1126/scitranslmed.aaa7582.

24.

Repeat Courses of Stereotactic Radiosurgery (SRS), Deferring Whole-Brain Irradiation, for New Brain Metastases After Initial SRS.

Shultz DB, Modlin LA, Jayachandran P, Von Eyben R, Gibbs IC, Choi CYH, Chang SD, Harsh GR 4th, Li G, Adler JR, Hancock SL, Soltys SG.

Int J Radiat Oncol Biol Phys. 2015 Aug 1;92(5):993-999. doi: 10.1016/j.ijrobp.2015.04.036. Epub 2015 Apr 28.

PMID:
26194677
25.

Inflammatory Pseudotumors of the Skull Base: Meta-Analysis.

Alyono JC, Shi Y, Berry GJ, Recht LD, Harsh GR 4th, Jackler RK, Corrales CE.

Otol Neurotol. 2015 Sep;36(8):1432-8. doi: 10.1097/MAO.0000000000000818.

PMID:
26164448
26.

Lineage-specific splicing of a brain-enriched alternative exon promotes glioblastoma progression.

Ferrarese R, Harsh GR 4th, Yadav AK, Bug E, Maticzka D, Reichardt W, Dombrowski SM, Miller TE, Masilamani AP, Dai F, Kim H, Hadler M, Scholtens DM, Yu IL, Beck J, Srinivasasainagendra V, Costa F, Baxan N, Pfeifer D, von Elverfeldt D, Backofen R, Weyerbrock A, Duarte CW, He X, Prinz M, Chandler JP, Vogel H, Chakravarti A, Rich JN, Carro MS, Bredel M.

J Clin Invest. 2014 Jul;124(7):2861-76. doi: 10.1172/JCI68836. Epub 2014 May 27.

27.

Endoscopic transtubular resection of a colloid cyst.

Ajlan AM, Kalani MA, Harsh GR.

Neurosciences (Riyadh). 2014 Jan;19(1):43-6.

PMID:
24419449
28.

Functional pituitary adenoma recurrence after surgical resection.

Ajlan AM, Harsh GR 4th.

World Neurosurg. 2014 Mar-Apr;81(3-4):494-6. doi: 10.1016/j.wneu.2013.11.001. Epub 2013 Nov 9. No abstract available.

PMID:
24215871
29.

Risk of leptomeningeal disease in patients treated with stereotactic radiosurgery targeting the postoperative resection cavity for brain metastases.

Atalar B, Modlin LA, Choi CY, Adler JR, Gibbs IC, Chang SD, Harsh GR 4th, Li G, Nagpal S, Hanlon A, Soltys SG.

Int J Radiat Oncol Biol Phys. 2013 Nov 15;87(4):713-8. doi: 10.1016/j.ijrobp.2013.07.034. Epub 2013 Sep 18.

PMID:
24054875
30.

The human factor and safety attitudes in neurosurgical operating rooms.

Ajlan AM, Harsh GR 4th.

World Neurosurg. 2015 Jan;83(1):46-8. doi: 10.1016/j.wneu.2013.08.039. Epub 2013 Sep 3. No abstract available.

PMID:
24012553
31.

Multi-institutional validation of a preoperative scoring system which predicts survival for patients with glioblastoma.

Chaichana KL, Pendleton C, Chambless L, Camara-Quintana J, Nathan JK, Hassam-Malani L, Li G, Harsh GR 4th, Thompson RC, Lim M, Quinones-Hinojosa A.

J Clin Neurosci. 2013 Oct;20(10):1422-6. doi: 10.1016/j.jocn.2013.02.007. Epub 2013 Aug 6.

32.

CyberKnife radiosurgery for the management of skull base and spinal chondrosarcomas.

Jiang B, Veeravagu A, Feroze AH, Lee M, Harsh GR, Soltys SG, Gibbs IC, Adler JR, Chang SD.

J Neurooncol. 2013 Sep;114(2):209-18. doi: 10.1007/s11060-013-1172-9. Epub 2013 Jun 8.

PMID:
23748573
33.

Cavity volume dynamics after resection of brain metastases and timing of postresection cavity stereotactic radiosurgery.

Atalar B, Choi CY, Harsh GR 4th, Chang SD, Gibbs IC, Adler JR, Soltys SG.

Neurosurgery. 2013 Feb;72(2):180-5; discussion 185. doi: 10.1227/NEU.0b013e31827b99f3.

PMID:
23149969
34.

A perspective on craniopharyngioma.

Lober RM, Harsh GR 4th.

World Neurosurg. 2013 May-Jun;79(5-6):645-6. doi: 10.1016/j.wneu.2012.10.064. Epub 2012 Oct 27. No abstract available.

PMID:
23111221
35.

Management of intracranial and extracranial chordomas with CyberKnife stereotactic radiosurgery.

Jiang B, Veeravagu A, Lee M, Harsh GR, Lieberson RE, Bhatti I, Soltys SG, Gibbs IC, Adler JR, Chang SD.

J Clin Neurosci. 2012 Aug;19(8):1101-6. doi: 10.1016/j.jocn.2012.01.005. Epub 2012 Jun 20.

PMID:
22727205
36.

Stereotactic radiosurgery of the postoperative resection cavity for brain metastases: prospective evaluation of target margin on tumor control.

Choi CY, Chang SD, Gibbs IC, Adler JR, Harsh GR 4th, Lieberson RE, Soltys SG.

Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):336-42. doi: 10.1016/j.ijrobp.2011.12.009. Epub 2012 May 30.

PMID:
22652105
37.

Cochlea radiation dose correlates with hearing loss after stereotactic radiosurgery of vestibular schwannoma.

Hayden Gephart MG, Hansasuta A, Balise RR, Choi C, Sakamoto GT, Venteicher AS, Soltys SG, Gibbs IC, Harsh GR, Adler JR, Chang SD.

World Neurosurg. 2013 Sep-Oct;80(3-4):359-63. doi: 10.1016/j.wneu.2012.04.001. Epub 2012 Apr 5.

PMID:
22484770
38.

The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors.

Willingham SB, Volkmer JP, Gentles AJ, Sahoo D, Dalerba P, Mitra SS, Wang J, Contreras-Trujillo H, Martin R, Cohen JD, Lovelace P, Scheeren FA, Chao MP, Weiskopf K, Tang C, Volkmer AK, Naik TJ, Storm TA, Mosley AR, Edris B, Schmid SM, Sun CK, Chua MS, Murillo O, Rajendran P, Cha AC, Chin RK, Kim D, Adorno M, Raveh T, Tseng D, Jaiswal S, Enger PØ, Steinberg GK, Li G, So SK, Majeti R, Harsh GR, van de Rijn M, Teng NN, Sunwoo JB, Alizadeh AA, Clarke MF, Weissman IL.

Proc Natl Acad Sci U S A. 2012 Apr 24;109(17):6662-7. doi: 10.1073/pnas.1121623109. Epub 2012 Mar 26.

39.

What is the optimal treatment of large brain metastases? An argument for a multidisciplinary approach.

Choi CY, Chang SD, Gibbs IC, Adler JR, Harsh GR 4th, Atalar B, Lieberson RE, Soltys SG.

Int J Radiat Oncol Biol Phys. 2012 Nov 1;84(3):688-93. doi: 10.1016/j.ijrobp.2012.01.028. Epub 2012 Mar 22.

PMID:
22445007
40.

The predictive value of serum myeloperoxidase for vasospasm in patients with aneurysmal subarachnoid hemorrhage.

Lim M, Bower RS, Wang Y, Sims L, Bower MR, Camara-Quintana J, Li G, Cheshier S, Harsh GR 4th, Steinberg GK, Guccione S.

Neurosurg Rev. 2012 Jul;35(3):413-9; discussion 419. doi: 10.1007/s10143-012-0375-4. Epub 2012 Feb 28.

PMID:
22370810
41.

Gene-protein correlation in single cells.

Renfrow JJ, Scheck AC, Dhawan NS, Lukac PJ, Vogel H, Chandler JP, Raizer JJ, Harsh GR, Chakravarti A, Bredel M.

Neuro Oncol. 2011 Aug;13(8):880-5. doi: 10.1093/neuonc/nor071.

42.

Multisession stereotactic radiosurgery for vestibular schwannomas: single-institution experience with 383 cases.

Hansasuta A, Choi CY, Gibbs IC, Soltys SG, Tse VC, Lieberson RE, Hayden MG, Sakamoto GT, Harsh GR 4th, Adler JR Jr, Chang SD.

Neurosurgery. 2011 Dec;69(6):1200-9. doi: 10.1227/NEU.0b013e318222e451.

PMID:
21558974
43.

The dynamics of post-operative plasma ACTH values following transsphenoidal surgery for Cushing's disease.

Srinivasan L, Laws ER, Dodd RL, Monita MM, Tannenbaum CE, Kirkeby KM, Chu OS, Harsh GR 4th, Katznelson L.

Pituitary. 2011 Dec;14(4):312-7. doi: 10.1007/s11102-011-0295-2.

PMID:
21298507
44.

Stereotactic radiosurgery of cranial nonvestibular schwannomas: results of single- and multisession radiosurgery.

Choi CY, Soltys SG, Gibbs IC, Harsh GR, Sakamoto GT, Patel DA, Lieberson RE, Chang SD, Adler JR.

Neurosurgery. 2011 May;68(5):1200-8; discussion 1208. doi: 10.1227/NEU.0b013e31820c0474.

PMID:
21273918
45.

NFKBIA deletion in glioblastomas.

Bredel M, Scholtens DM, Yadav AK, Alvarez AA, Renfrow JJ, Chandler JP, Yu IL, Carro MS, Dai F, Tagge MJ, Ferrarese R, Bredel C, Phillips HS, Lukac PJ, Robe PA, Weyerbrock A, Vogel H, Dubner S, Mobley B, He X, Scheck AC, Sikic BI, Aldape KD, Chakravarti A, Harsh GR 4th.

N Engl J Med. 2011 Feb 17;364(7):627-37. doi: 10.1056/NEJMoa1006312. Epub 2010 Dec 22.

46.

Cyberknife stereotactic radiosurgery for treatment of atypical (WHO grade II) cranial meningiomas.

Choi CY, Soltys SG, Gibbs IC, Harsh GR, Jackson PS, Lieberson RE, Chang SD, Adler JR.

Neurosurgery. 2010 Nov;67(5):1180-8. doi: 10.1227/NEU.0b013e3181f2f427.

PMID:
20871435
47.

Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice.

Kioi M, Vogel H, Schultz G, Hoffman RM, Harsh GR, Brown JM.

J Clin Invest. 2010 Mar;120(3):694-705. doi: 10.1172/JCI40283. Epub 2010 Feb 22.

48.

An RNAi screen identifies TRRAP as a regulator of brain tumor-initiating cell differentiation.

Wurdak H, Zhu S, Romero A, Lorger M, Watson J, Chiang CY, Zhang J, Natu VS, Lairson LL, Walker JR, Trussell CM, Harsh GR, Vogel H, Felding-Habermann B, Orth AP, Miraglia LJ, Rines DR, Skirboll SL, Schultz PG.

Cell Stem Cell. 2010 Jan 8;6(1):37-47. doi: 10.1016/j.stem.2009.11.002.

49.

Passive antibody-mediated immunotherapy for the treatment of malignant gliomas.

Mitra S, Li G, Harsh GR 4th.

Neurosurg Clin N Am. 2010 Jan;21(1):67-76. doi: 10.1016/j.nec.2009.08.010. Review.

PMID:
19944967
50.

Monosomy of chromosome 10 associated with dysregulation of epidermal growth factor signaling in glioblastomas.

Yadav AK, Renfrow JJ, Scholtens DM, Xie H, Duran GE, Bredel C, Vogel H, Chandler JP, Chakravarti A, Robe PA, Das S, Scheck AC, Kessler JA, Soares MB, Sikic BI, Harsh GR, Bredel M.

JAMA. 2009 Jul 15;302(3):276-89. doi: 10.1001/jama.2009.1022.

Supplemental Content

Loading ...
Support Center